Fibromyalgia: Open Access
Open Access
Guafensin Fibromyalgia
Search results for
Guafensin Fibromyalgia
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
Useful Links
Share This Page
Guafensin Fibromyalgia
Guafensin is an expectorant. If it is related to the physical body then guafensin will have no results. It has not been approved by the FDA for the treatment of fibromyalgia. The protocol involves three parts initially titrating the guafesin, avoiding salicylates and a low carbohydrate diet. It has been claimed that guaifenesin increases the excretion of uric acid and possibly to increase phosphate excretion.
Related journals of Guafensin Fibromyalgia
Fibromyalgia: Open Access, International Journal of Physical Medicine & Rehabilitation, Rheumatology: Current Research, Journal of Sports Medicine & Doping Studies, Journal of Yoga & Physical Therapy, Myalgia And Myositis, Skeletal Muscle Journal, Sarcopenia and Muscle, Muscle & nerve.
Guafensin Fibromyalgia
Speaker PPTs
- Kirill Shlyapnikov
Fibromyalgia and chronic fatigue syndrome (CFS): translational biomarkers as applicable to monitor and to predict clinical manifestations
PPT Version | PDF Version